Skip to main content
. 2022 May 16;16:1391. doi: 10.3332/ecancer.2022.1391

Table 4. Comparative mean [one-way ANOVA (post-hoc)] analysis of different serum parameters across different grades identified in brain tumour patients who participated, Addis Ababa, Ethiopia, 2020.

Serum parameter Tumour grade
Grade I (N = 21)
Mean ± SD
Grade II (N = 14)
Mean ± SD
Grade III (N = 9)
Mean ± SD
Grade IV (N = 6)
Mean ± SD
GSH 11.96 ± 1.13a 11.10 ± 0.97a 10.14 ± 0.22 9.46 ± 0.46
GSSG 0.69 ± 0.02b 0.71 ± 0.015b 0.75 ± 0.029 0.74 ± 0.035
TOS 8.43 ± 1.56c 9.46 ± 0.77c 11.31 ± 0.79 11.96 ± 0.72
TAC 93.80 ± 4.49d 84.89 ± 8.39d 57.89 ± 7.25d 50.55 ± 3.14d
OSI 9.11 ± 1.79e 11.26 ± 1.54e 19.87 ± 3.25e 23.78 ± 2.65e
a

Significant mean difference in GSH

b

Significant mean difference in GSSG

c

Significant mean difference in TOS

d

Significant mean difference in TAC

e

Significant mean difference in OSI